Literature DB >> 6304810

Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.

V W Lee, A G Caldarone, R H Falk, A Rubinow, A S Cohen.   

Abstract

A prospective, comparative study was made of the efficacy of technetium-99m pyrophosphate (Tc PYP) and technetium-99m methylene diphosphonate (Tc MDP) in detecting soft-tissue amyloidosis. Tc PYP and Tc MDP scans were obtained within ten-day intervals in seven patients with histologically proven amyloidosis. Tc PYP was a better scanning agent for soft-tissue amyloidosis in all patients. Cardiac and hepatic involvement were proved by autopsy in one patient. Involvement of the heart was confirmed by echocardiography in five patients. The potential use of Tc PYP scanning as a screening test for soft-tissue amyloidosis is discussed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6304810     DOI： 10.1148/radiology.148.1.6304810

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  19 in total

1.  Isolated ectopic lung uptake of technetium 99m methylene diphosphonate on bone scintigraphy in primary amyloidosis.

Authors:  S T Zwas; O Shpilberg; M Huszar; J Rozenman
Journal:  Eur J Nucl Med       Date:  1990

2.  (99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis.

Authors:  Arnault Galat; Axel Van Der Gucht; Magali Colombat; David Attias; Emmanuel Itti; Michel Meignan; Fabien Lebras; Valérie Molinier-Frenkel; Nicole Benhaiem; Aziz Guellich; Jean Rosso; Thibaud Damy
Journal:  J Nucl Cardiol       Date:  2015-05-22       Impact factor: 5.952

3.  Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis.

Authors:  Rodney H Falk; Sharmila Dorbala
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03       Impact factor: 9.236

Review 4.  Restrictive cardiomyopathy.

Authors:  P T Wilmshurst; D Katritsis
Journal:  Br Heart J       Date:  1990-06

5.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

6.  Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.

Authors:  Francesco Cappelli; Chiara Gallini; Carlo Di Mario; Egidio Natalino Costanzo; Luca Vaggelli; Francesca Tutino; Alfonso Ciaccio; Simone Bartolini; Paola Angelotti; Sabrina Frusconi; Silvia Farsetti; Giuseppe Vergaro; Assuero Giorgetti; Paolo Marzullo; Dario Genovesi; Michele Emdin; Federico Perfetto
Journal:  J Nucl Cardiol       Date:  2017-05-23       Impact factor: 5.952

Review 7.  Molecular imaging of amyloidosis: will the heart be the next target after the brain?

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

8.  Demonstration of primary tracheobronchial amyloidosis by 99mTc-HMDP bone SPECT.

Authors:  S Yoshida; T Suematsu; T Koizumi; T Motohara; K Oobayashi; Y Takada; H Yamamoto; T Sashikata
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

9.  Spontaneous rupture of the spleen and liver in amyloidosis--a case report and review of the literature.

Authors:  K Okazaki; F Moriyasu; T Shiomura; T Yamamoto; T Suzaki; Y Kanematsu; S Akasaka; Y Kobashi
Journal:  Gastroenterol Jpn       Date:  1986-10

10.  Soft-tissue uptake of 99mTc-diphosphonate in systemic AL amyloidosis.

Authors:  S Janssen; M H van Rijswijk; D A Piers; G M de Jong
Journal:  Eur J Nucl Med       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.